SorLA Monoclonal Antibody

This gene encodes a mosaic protein that belongs to at least two families: the vacuolar protein sorting 10 (VPS10) domain-containing receptor family, and the low density lipoprotein receptor (LDLR) family. The encoded protein also contains fibronectin type III repeats and an epidermal growth factor repeat. The encoded preproprotein is proteolytically processed to generate the mature receptor, which likely plays roles in endocytosis and sorting. Mutations in this gene may be associated with Alzheimer's disease.

Introducing the SORLA Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of molecular research. This meticulously crafted product is meticulously engineered to target and bind to the SORLA protein, a key player in various cellular processes.

The SORLA Monoclonal Antibody boasts an exceptional level of specificity and affinity, ensuring unparalleled accuracy and reliability in experimental settings. Its superior performance is attributed to the rigorous selection and optimization of its hybridoma cell line, resulting in a highly potent and stable antibody formulation.

With its remarkable versatility, the SORLA Monoclonal Antibody is an invaluable tool for elucidating the intricate mechanisms underlying SORLA-mediated pathways. Its application extends to a wide range of scientific disciplines, including but not limited to neuroscience, immunology, and oncology.

This groundbreaking product is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures to guarantee consistency and reproducibility. Each batch of the SORLA Monoclonal Antibody undergoes rigorous testing to ensure its purity, potency, and absence of contaminants, thereby ensuring optimal experimental outcomes.

Furthermore, the SORLA Monoclonal Antibody is conveniently available in various formats, including purified, conjugated, and labeled options, catering to diverse experimental requirements. Its compatibility with a multitude of techniques, such as immunohistochemistry, western blotting, and flow cytometry, further enhances its versatility and applicability.

In summary, the SORLA Monoclonal Antibody represents a pinnacle of scientific achievement, offering researchers an indispensable tool to unravel the complexities of SORLA-related processes. Its exceptional specificity, reliability, and compatibility make it an indispensable asset in the pursuit of groundbreaking discoveries and advancements in the realm of molecular biology.